{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T03:03:14Z","timestamp":1787626994520,"version":"build-2736575974"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T00:00:00Z","timestamp":1696636800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001230","name":"Macquarie University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.arr.2023.102085","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T04:41:59Z","timestamp":1696826519000},"page":"102085","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["TDP-43 as a therapeutic target in neurodegenerative diseases: Focusing on motor neuron disease and frontotemporal dementia"],"prefix":"10.1016","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7743-0565","authenticated-orcid":false,"given":"Afshin","family":"Babazadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie L.","family":"Rayner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2023.102085_bib1","first-page":"1","article-title":"Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation. Nature","volume":"8","author":"Afroz","year":"2017","journal-title":"Communications"},{"key":"10.1016\/j.arr.2023.102085_bib2","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/neup.12138","article-title":"Significance and limitation of the pathological classification of TDP\u201043 proteinopathy","volume":"34","author":"Arai","year":"2014","journal-title":"Neuropathology"},{"key":"10.1016\/j.arr.2023.102085_bib3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00401-008-0480-1","article-title":"Phosphorylated TDP-43 in Alzheimer\u2019s disease and dementia with Lewy bodies","volume":"117","author":"Arai","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2023.102085_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/21678421.2019.1672749","article-title":"HSC70 expression is reduced in lymphomonocytes of sporadic ALS patients and contributes to TDP-43 accumulation","volume":"21","author":"Arosio","year":"2020","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"10.1016\/j.arr.2023.102085_bib5","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1242\/jcs.038950","article-title":"Structural determinants of the cellular localization and shuttling of TDP-43","volume":"121","author":"Ayala","year":"2008","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.arr.2023.102085_bib6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jconrel.2020.02.015","article-title":"Nanocarrier-mediated brain delivery of bioactives for treatment\/prevention of neurodegenerative diseases","volume":"321","author":"Babazadeh","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.arr.2023.102085_bib7","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nchembio.1563","article-title":"Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models","volume":"10","author":"Barmada","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.arr.2023.102085_bib8","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nature22038","article-title":"Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice","volume":"544","author":"Becker","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.arr.2023.102085_bib9","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.4103\/1673-5374.262578","article-title":"Rethinking to riluzole mechanism of action: The molecular link among protein kinase CK1\u03b4 activity, TDP-43 phosphorylation, and amyotrophic lateral sclerosis pharmacological treatment","volume":"14","author":"Bissaro","year":"2019","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.arr.2023.102085_bib10","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nrd.2018.109","article-title":"Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing","volume":"17","author":"Boland","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.arr.2023.102085_bib11","first-page":"1","article-title":"Antisense oligonucleotides for the study and treatment of ALS","author":"Boros","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.arr.2023.102085_bib12","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nrneurol.2013.221","article-title":"Amyotrophic lateral sclerosis\u2014a model of corticofugal axonal spread","volume":"9","author":"Braak","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2023.102085_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.adgen.2015.07.001","article-title":"Functional significance of TDP-43 mutations in disease","volume":"91","author":"Buratti","year":"2015","journal-title":"Adv. Genet."},{"key":"10.1016\/j.arr.2023.102085_bib14","doi-asserted-by":"crossref","first-page":"27416","DOI":"10.1074\/jbc.M109.031278","article-title":"Rapamycin rescues TDP-43 mislocalization and the associated low molecular mass neurofilament instability","volume":"284","author":"Caccamo","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2023.102085_bib15","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fimmu.2019.00362","article-title":"Therapeutic inhibition of the complement system in diseases of the central nervous system","volume":"10","author":"Carpanini","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.arr.2023.102085_bib16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-510X(99)00210-5","article-title":"The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function","volume":"169","author":"Cedarbaum","year":"1999","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.arr.2023.102085_bib17","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.febslet.2015.06.009","article-title":"TDP-35 sequesters TDP-43 into cytoplasmic inclusions through binding with RNA","volume":"589","author":"Che","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.arr.2023.102085_bib18","article-title":"Tamoxifen for amyotrophic lateral sclerosis: a randomized double-blind clinical trial","volume":"99","author":"Chen","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.arr.2023.102085_bib19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/01677063.2015.1077832","article-title":"Rapamycin alleviates pathogenesis of a new Drosophila model of ALS-TDP","volume":"29","author":"Cheng","year":"2015","journal-title":"J. Neurogenet."},{"key":"10.1016\/j.arr.2023.102085_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-019-0310-z","article-title":"Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy","volume":"14","author":"Chew","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2023.102085_bib21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S1474-4422(17)30401-5","article-title":"Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications","volume":"17","author":"Chia","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2023.102085_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-29658-2","article-title":"Tdp-25 routing to autophagy and proteasome ameliorates its aggregation in amyotrophic lateral sclerosis target cells","volume":"8","author":"Cicardi","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2023.102085_bib23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fnins.2017.00185","article-title":"Protein quality control by molecular chaperones in neurodegeneration","volume":"11","author":"Ciechanover","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2023.102085_bib24","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/sj.cdd.4401751","article-title":"Autophagy and signaling: their role in cell survival and cell death","volume":"12","author":"Codogno","year":"2005","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.arr.2023.102085_bib25","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.1038\/ncomms6845","article-title":"An acetylation switch controls TDP-43 function and aggregation propensity","volume":"6","author":"Cohen","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2023.102085_bib26","first-page":"774","article-title":"C9orf72 poly (GR) aggregation induces TDP-43 proteinopathy","author":"Cook","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.arr.2023.102085_bib27","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.celrep.2017.09.028","article-title":"Post-transcriptional inhibition of Hsc70-4\/HSPA8 expression leads to synaptic vesicle cycling defects in multiple models of ALS","volume":"21","author":"Coyne","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.arr.2023.102085_bib28","doi-asserted-by":"crossref","unstructured":"Coyne, A.N., Zaepfel, B.L., Zarnescu, D.C., 2017b. Failure to deliver and translate\u2014new insights into RNA dysregulation in ALS. Front. Cell. Neurosci. 11, 243.","DOI":"10.3389\/fncel.2017.00243"},{"key":"10.1016\/j.arr.2023.102085_bib29","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.3390\/cancers11101422","article-title":"The emerging roles of mTORC1 in macromanaging autophagy","volume":"11","author":"Dossou","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.arr.2023.102085_bib30","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1185\/03007995.2011.583229","article-title":"Dalfampridine: a brief review of its mechanism of action and efficacy as a treatment to improve walking in patients with multiple sclerosis","volume":"27","author":"Dunn","year":"2011","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.arr.2023.102085_bib31","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature09320","article-title":"Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS","volume":"466","author":"Elden","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.arr.2023.102085_bib32","first-page":"1","article-title":"Buntanetap, a novel translational inhibitor of multiple neurotoxic proteins, proves to be safe and promising in both Alzheimer\u2019s and Parkinson\u2019s patients","author":"Fang","year":"2022","journal-title":"J. Prev. Alzheimer'S. Dis."},{"key":"10.1016\/j.arr.2023.102085_bib33","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1038\/ncomms5824","article-title":"Full-length TDP-43 forms toxic amyloid oligomers that are present in frontotemporal lobar dementia-TDP patients","volume":"5","author":"Fang","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2023.102085_bib34","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020106177","article-title":"HDAC6 inhibition restores TDP\u201043 pathology and axonal transport defects in human motor neurons with TARDBP mutations","volume":"40","author":"Fazal","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.arr.2023.102085_bib35","doi-asserted-by":"crossref","first-page":"7789","DOI":"10.1007\/s12035-018-0947-6","article-title":"Towards a TDP-43-based biomarker for ALS and FTLD","volume":"55","author":"Feneberg","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2023.102085_bib36","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202050219","article-title":"Loss of TMEM 106B and PGRN leads to severe lysosomal abnormalities and neurodegeneration in mice","volume":"21","author":"Feng","year":"2020","journal-title":"EMBO Rep."},{"key":"10.1016\/j.arr.2023.102085_bib37","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.bioorg.2018.11.042","article-title":"TDP-43 specific reduction induced by Di-hydrophobic tags conjugated peptides","volume":"84","author":"Gao","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.arr.2023.102085_bib38","first-page":"3024","article-title":"Metabolism and mis-metabolism of the neuropathological signature protein TDP-43","volume":"127","author":"Huang","year":"2014","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.arr.2023.102085_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-020-0881-5","article-title":"A robust TDP-43 knock-in mouse model of ALS","volume":"8","author":"Huang","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.arr.2023.102085_bib40","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-033131","article-title":"Induced pluripotent stem cell\u2013based Drug Repurposing for Amyotrophic lateral sclerosis Medicine (iDReAM) study: protocol for a phase I dose escalation study of bosutinib for amyotrophic lateral sclerosis patients","volume":"9","author":"Imamura","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.arr.2023.102085_bib41","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3109\/17482968.2012.686511","article-title":"Impaired proteasome function in sporadic amyotrophic lateral sclerosis","volume":"13","author":"Kabashi","year":"2012","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.arr.2023.102085_bib42","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41580-018-0001-6","article-title":"The coming of age of chaperone-mediated autophagy","volume":"19","author":"Kaushik","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.arr.2023.102085_bib43","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00401-015-1486-0","article-title":"Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS","volume":"130","author":"Ke","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2023.102085_bib44","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1093\/emboj\/cdg227","article-title":"For whom the bell tolls: protein quality control of the endoplasmic reticulum and the ubiquitin\u2013proteasome connection","volume":"22","author":"Kostova","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.arr.2023.102085_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-020-00420-5","article-title":"Induction of autophagy mitigates TDP-43 pathology and translational repression of neurofilament mRNAs in mouse models of ALS\/FTD","volume":"16","author":"Kumar","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2023.102085_bib46","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/nar\/gkp013","article-title":"Structural insights into TDP-43 in nucleic-acid binding and domain interactions","volume":"37","author":"Kuo","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.arr.2023.102085_bib47","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1093\/nar\/gkt1407","article-title":"The crystal structure of TDP-43 RRM1-DNA complex reveals the specific recognition for UG-and TG-rich nucleic acids","volume":"42","author":"Kuo","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.arr.2023.102085_bib48","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1126\/science.aba4624","article-title":"Antisense oligonucleotides for neurodegeneration","volume":"367","author":"Leavitt","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.arr.2023.102085_bib49","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature09299","article-title":"Enhancement of proteasome activity by a small-molecule inhibitor of USP14","volume":"467","author":"Lee","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.arr.2023.102085_bib50","first-page":"14","article-title":"TDP-43 cytoplasmic inclusion formation is disrupted in C9orf72-associated amyotrophic lateral sclerosis\/frontotemporal lobar degeneration","author":"Lee","year":"2019","journal-title":"Brain Commun. 1, fcz0"},{"key":"10.1016\/j.arr.2023.102085_bib51","first-page":"1","article-title":"The cleavage pattern of TDP-43 determines its rate of clearance and cytotoxicity","volume":"6","author":"Li","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2023.102085_bib52","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1083\/jcb.201302044","article-title":"Stress granules as crucibles of ALS pathogenesis","volume":"201","author":"Li","year":"2013","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.arr.2023.102085_bib53","doi-asserted-by":"crossref","first-page":"13318","DOI":"10.1073\/pnas.1008227107","article-title":"ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS\/TLS","volume":"107","author":"Ling","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2023.102085_bib54","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.neuron.2013.07.033","article-title":"Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis","volume":"79","author":"Ling","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2023.102085_bib55","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fneur.2019.00293","article-title":"ROCK-ALS: protocol for a randomized, placebo-controlled, double-blind phase IIa trial of safety, tolerability and efficacy of the rho kinase (ROCK) inhibitor fasudil in amyotrophic lateral sclerosis","author":"Lingor","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.arr.2023.102085_bib56","doi-asserted-by":"crossref","first-page":"E7176","DOI":"10.1073\/pnas.1522332112","article-title":"cAMP-induced phosphorylation of 26S proteasomes on Rpn6\/PSMD11 enhances their activity and the degradation of misfolded proteins","volume":"112","author":"Lokireddy","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2023.102085_bib57","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00401-011-0845-8","article-title":"A harmonized classification system for FTLD-TDP pathology","volume":"122","author":"Mackenzie","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2023.102085_bib58","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.molcel.2020.07.018","article-title":"TDP-43 nuclear bodies: a NEAT response to stress?","volume":"79","author":"Malik","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.arr.2023.102085_bib59","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028486","article-title":"Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS)","volume":"9","author":"Mandrioli","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.arr.2023.102085_bib60","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00401-021-02330-2","article-title":"TMEM106B modifies TDP-43 pathology in human ALS brain and cell-based models of TDP-43 proteinopathy","volume":"142","author":"Mao","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2023.102085_bib61","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/13543784.2023.2178416","article-title":"Emerging clinical investigational drugs for the treatment of amyotrophic lateral sclerosis","volume":"32","author":"Martinez-Gonzalez","year":"2023","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.arr.2023.102085_bib62","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1021\/acschembio.0c00494","article-title":"An allosteric modulator of RNA binding targeting the N-terminal domain of TDP-43 yields neuroprotective properties","volume":"15","author":"Mollasalehi","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.arr.2023.102085_bib63","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00401-011-0907-y","article-title":"Clinical and neuropathologic heterogeneity of c9FTD\/ALS associated with hexanucleotide repeat expansion in C9ORF72","volume":"122","author":"Murray","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2023.102085_bib64","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nchembio.597","article-title":"Small-molecule hydrophobic tagging\u2013induced degradation of HaloTag fusion proteins","volume":"7","author":"Neklesa","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.arr.2023.102085_bib65","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.arr.2023.102085_bib66","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/nen.0b013e31803020b9","article-title":"TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations","volume":"66","author":"Neumann","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.arr.2023.102085_bib67","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.tig.2018.03.001","article-title":"ALS genes in the genomic era and their implications for FTD","volume":"34","author":"Nguyen","year":"2018","journal-title":"Trends Genet."},{"key":"10.1016\/j.arr.2023.102085_bib68","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.tips.2019.12.002","article-title":"Ropinirole, a new ALS drug candidate developed using iPSCs","volume":"41","author":"Okano","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.arr.2023.102085_bib69","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fnmol.2020.00019","article-title":"Chaperone mediated autophagy degrades TDP-43 protein and is affected by TDP-43 aggregation","volume":"13","author":"Orme\u00f1o","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.arr.2023.102085_bib70","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.bbrc.2016.02.107","article-title":"Disturbance of proteasomal and autophagic protein degradation pathways by amyotrophic lateral sclerosis-linked mutations in ubiquilin 2","volume":"472","author":"Osaka","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.arr.2023.102085_bib71","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1128\/jvi.69.6.3584-3596.1995","article-title":"Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs","volume":"69","author":"Ou","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.arr.2023.102085_bib72","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMoa1916945","article-title":"Trial of sodium phenylbutyrate\u2013taurursodiol for amyotrophic lateral sclerosis","volume":"383","author":"Paganoni","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2023.102085_bib73","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/mus.27091","article-title":"Long\u2010term survival of participants in the CENTAUR trial of sodium phenylbutyrate\u2010taurursodiol in amyotrophic lateral sclerosis","volume":"63","author":"Paganoni","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.arr.2023.102085_bib74","doi-asserted-by":"crossref","unstructured":"Parker, S.J., Meyerowitz, J., James, J.L., Liddell, J.R., Nonaka, T., Hasegawa, M., Kanninen, K.M., Lim, S., Paterson, B.M., Donnelly, P.S., 2012. Inhibition of TDP-43 accumulation by bis (thiosemicarbazonato)-copper complexes.","DOI":"10.1371\/journal.pone.0042277"},{"key":"10.1016\/j.arr.2023.102085_bib75","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.aax3769","article-title":"Cellular quality control by the ubiquitin-proteasome system and autophagy","volume":"366","author":"Pohl","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.arr.2023.102085_bib76","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3389\/fnins.2019.00532","article-title":"Motor neuron susceptibility in ALS\/FTD","volume":"13","author":"Ragagnin","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2023.102085_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-017-0208-6","article-title":"The heat shock response in neurons and astroglia and its role in neurodegenerative diseases","volume":"12","author":"San Gil","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2023.102085_bib78","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/NEN.0b013e3182160690","article-title":"Autophagy in spinal cord motor neurons in sporadic amyotrophic lateral sclerosis","volume":"70","author":"Sasaki","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.arr.2023.102085_bib79","first-page":"1263","article-title":"Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species","volume":"127","author":"Scotter","year":"2014","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.arr.2023.102085_bib80","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4161\/auto.36098","article-title":"Mutations in the ubiquitin-binding domain of OPTN\/optineurin interfere with autophagy-mediated degradation of misfolded proteins by a dominant-negative mechanism","volume":"11","author":"Shen","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.arr.2023.102085_bib81","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/brain\/awz419","article-title":"Distinct responses of neurons and astrocytes to TDP-43 proteinopathy in amyotrophic lateral sclerosis","volume":"143","author":"Smethurst","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.arr.2023.102085_bib82","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3390\/ph15070842","article-title":"The protective effect of edaravone on TDP-43 plus oxidative stress-induced neurotoxicity in neuronal cells: analysis of its neuroprotective mechanisms using RNA sequencing","volume":"15","author":"Soejima-Kusunoki","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.arr.2023.102085_bib83","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00401-007-0206-9","article-title":"TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation","volume":"113","author":"Tan","year":"2007","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2023.102085_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-014-0078-x","article-title":"Possible involvement of lysosomal dysfunction in pathological changes of the brain in aged progranulin-deficient mice","volume":"2","author":"Tanaka","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.arr.2023.102085_bib85","doi-asserted-by":"crossref","first-page":"42984","DOI":"10.1074\/jbc.M112.417600","article-title":"Motor neuron-specific disruption of proteasomes, but not autophagy, replicates amyotrophic lateral sclerosis","volume":"287","author":"Tashiro","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2023.102085_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-018-0237-9","article-title":"Pathological phosphorylation of tau and TDP-43 by TTBK1 and TTBK2 drives neurodegeneration","volume":"13","author":"Taylor","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2023.102085_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep19118","article-title":"CUL2-mediated clearance of misfolded TDP-43 is paradoxically affected by VHL in oligodendrocytes in ALS","volume":"6","author":"Uchida","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2023.102085_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022850","article-title":"Cytoplasmic accumulation and aggregation of TDP-43 upon proteasome inhibition in cultured neurons","volume":"6","author":"van Eersel","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.arr.2023.102085_bib89","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1212\/WNL.0000000000004606","article-title":"Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials","volume":"89","author":"van Eijk","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2023.102085_bib90","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1111\/febs.14323","article-title":"Neurophagy, the phagocytosis of live neurons and synapses by glia, contributes to brain development and disease","volume":"285","author":"Vilalta","year":"2018","journal-title":"FEBS J."},{"key":"10.1016\/j.arr.2023.102085_bib91","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.brainres.2009.09.105","article-title":"Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper\/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS)","volume":"1305","author":"Volkening","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.arr.2023.102085_bib92","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-041479","article-title":"Study protocol of RESCUE-ALS: A Phase 2, randomised, double-blind, placebo-controlled study in early symptomatic amyotrophic lateral sclerosis patients to assess bioenergetic catalysis with CNM-Au8 as a mechanism to slow disease progression","volume":"11","author":"Vucic","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.arr.2023.102085_bib93","first-page":"60","article-title":"Efficacy and safety of CNM-Au8 in amyotrophic lateral sclerosis (RESCUE-ALS study): a phase 2, randomised, double-blind, placebo-controlled trial and open label extension","author":"Vucic","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.arr.2023.102085_bib94","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081170","article-title":"ALS-associated TDP-43 induces endoplasmic reticulum stress, which drives cytoplasmic TDP-43 accumulation and stress granule formation","volume":"8","author":"Walker","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.arr.2023.102085_bib95","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00401-015-1460-x","article-title":"Functional recovery in new mouse models of ALS\/FTLD after clearance of pathological cytoplasmic TDP-43","volume":"130","author":"Walker","year":"2015","journal-title":"Acta Neuropathol."},{"issue":"443\u2013458","key":"10.1016\/j.arr.2023.102085_bib96","article-title":"Stress induces dynamic, cytotoxicity-antagonizing TDP-43 nuclear bodies via paraspeckle LncRNA NEAT1-mediated liquid-liquid phase separation","volume":"79","author":"Wang","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.arr.2023.102085_bib97","first-page":"1","article-title":"Acetylation-induced TDP-43 pathology is suppressed by an HSF1-dependent chaperone program","volume":"8","author":"Wang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2023.102085_bib98","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neulet.2009.11.055","article-title":"Degradation of TDP-43 and its pathogenic form by autophagy and the ubiquitin-proteasome system","volume":"469","author":"Wang","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2023.102085_bib99","doi-asserted-by":"crossref","first-page":"752","DOI":"10.7150\/ijbs.11880","article-title":"Valproate attenuates 25-kDa C-terminal fragment of TDP-43-induced neuronal toxicity via suppressing endoplasmic reticulum stress and activating autophagy","volume":"11","author":"Wang","year":"2015","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.arr.2023.102085_bib100","doi-asserted-by":"crossref","first-page":"15230","DOI":"10.1073\/pnas.1917371117","article-title":"ALS\/FTD mutations in UBQLN2 impede autophagy by reducing autophagosome acidification through loss of function","volume":"117","author":"Wu","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2023.102085_bib101","doi-asserted-by":"crossref","first-page":"27335","DOI":"10.1074\/jbc.M112.359000","article-title":"Targeted depletion of TDP-43 expression in the spinal cord motor neurons leads to the development of amyotrophic lateral sclerosis-like phenotypes in mice","volume":"287","author":"Wu","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2023.102085_bib102","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.freeradbiomed.2021.11.031","article-title":"Inflammation-dependent oxidative stress metabolites as a hallmark of amyotrophic lateral sclerosis","volume":"178","author":"Xiong","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.arr.2023.102085_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112981","article-title":"Proteolysis targeting chimera (PROTAC) in drug discovery paradigm: recent progress and future challenges","volume":"210","author":"Zeng","year":"2021","journal-title":"Eur. J. Med. Chem."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163723002441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163723002441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T19:18:25Z","timestamp":1761592705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163723002441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":103,"alternative-id":["S1568163723002441"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2023.102085","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TDP-43 as a therapeutic target in neurodegenerative diseases: Focusing on motor neuron disease and frontotemporal dementia","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2023.102085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102085"}}